Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE trial and BE BRIGHT open-label extension

被引：0
|
作者：
Sinclair, Rodney [1 ]
Thaci, Diamant [2 ]
Vender, Ronald [3 ]
de Rie, Menno [4 ]
Conrad, Curdin [5 ]
Soung, Jennifer [6 ]
Strober, Bruce [7 ,8 ]
Wang, Maggie [9 ]
Cross, Nancy [10 ]
Deherder, Delphine [9 ]
Gomez, Natalie Nunez [11 ]
Gottlieb, Alice B. [12 ]
机构：
[1] Sinclair Dermatol, East Melbourne, Vic, Australia
[2] Univ Lubeck, Lubeck, Germany
[3] Dermatrials Res Inc, Hamilton, ON, Canada
[4] Univ Amsterdam, Dept Dermatol, Med Ctr, Amsterdam, Netherlands
[5] Lausanne Univ Hosp, Dept Dermatol, Lausanne, Switzerland
[6] Southern Calif Dermatol, Santa Ana, CA USA
[7] Yale Univ, New Haven, CT USA
[8] Cent Connecticut Dermatol Res, Cromwell, CT USA
[9] UCB Pharma, Brussels, Belgium
[10] UCB, Morrisville, NC USA
[11] UCB Pharma, Monheim, Germany
[12] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [41] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [42] Long-Term Safety and Efficacy of Voxelotor for Patients with Sickle Cell Disease: Results from an Open-Label Extension of the Phase 3 HOPE Trial
    Achebe, Maureen
    Hassab, Hoda
    Alkindi, Salam
    Brown, R. Clark Clark
    Telfer, Paul
    Biemond, Bart J.
    Gordeuk, Victor R.
    Lipato, Thokozeni
    Tonda, Margaret
    Gray, Sarah
    Howard, Joanna
    [J]. BLOOD, 2021, 138
  • [43] Long term efficacy and safety of ustekinumab in patients with moderate to severe psoriasis through 5 years of follow-up: results from the PHOENIX 1 long-term extension
    Papp, K.
    Kimball, A.
    Wasfi, Y.
    Chan, D.
    Bissonnette, R.
    Sofen, H.
    Yeilding, N.
    Li, S.
    Szapary, P.
    Gordon, K.
    [J]. JOURNAL OF DERMATOLOGY, 2012, 39 : 239 - 240
  • [44] Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
    Zhao, Yan
    Li, Jing-Yi
    Yang, Bin
    Ding, Yang-Feng
    Wu, Li-Ming
    Zhang, Li-Tao
    Wang, Jin-Yan
    Lu, Qian-Jin
    Zhang, Chun-Lei
    Zhang, Fu-Ren
    Zhu, Xiao-Hong
    Li, Yu-Mei
    Tao, Xiao-Hua
    Diao, Qing-Chun
    Li, Lin-Feng
    Lu, Jian-Yun
    Man, Xiao-Yong
    Li, Fu-Qiu
    Xia, Xiu-Juan
    Song, Jiao-Ran
    Jia, Ying-Min
    Zhang, Li-Bo
    Chen, Bo
    Zhang, Jian-Zhong
    [J]. BIODRUGS, 2024, 38 (05) : 681 - 689
  • [45] Safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: Results from an open-label extension (OLE) trial up to 4 years
    Wollenberg, Andreas
    Soong, Weily
    Goooderham, Melinda
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB106 - AB106
  • [46] Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years
    Kimball, A. B.
    Gordon, K. B.
    Fakharzadeh, S.
    Yeilding, N.
    Szapary, P. O.
    Schenkel, B.
    Guzzo, C.
    Li, S.
    Papp, K. A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04) : 861 - 872
  • [47] Long-Term Safety and Efficacy of Open-Label Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Deleuran, Mette
    Thaci, Diamant
    Beck, Lisa A.
    Forman, Seth
    Soong, Weily
    Hussain, Iftikhar
    Bissonnette, Robert
    Bouaziz, Jean-David
    Gelfand, Joel
    Sher, Lawrence
    Chen, Zhen
    Akinlade, Bolanle
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Ardeleanu, Marius
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB381 - AB381
  • [48] Long-term safety and efficacy of open-label dupilumab in patients with moderate-to-severe atopic dermatitis
    Deleuran, M.
    Thaci, D.
    Beck, L.
    Forman, S.
    Soong, W.
    Hussain, I.
    Bissonnette, R.
    Bouaziz, J.
    Gelfand, J.
    Lawrence, S.
    Chen, Z.
    Akinlade, B.
    Gadkari, A.
    Eckert, L.
    Graham, N.
    Ardeleanu, M.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 34 - 34
  • [49] Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
    Deleuran, Mette
    Thaci, Diamant
    Beck, Lisa A.
    de Bruin-Weller, Marjolein
    Blauvelt, Andrew
    Forman, Seth
    Bissonnette, Robert
    Reich, Kristian
    Soong, Weily
    Hussain, Iftikhar
    Foley, Peter
    Hide, Michihiro
    Bouaziz, Jean-David
    Gelfand, Joel M.
    Sher, Lawrence
    Schuttelaar, Marie L. A.
    Wang, Chen
    Chen, Zhen
    Akinlade, Bolanle
    Gadkari, Abhijit
    Eckert, Laurent
    Davis, John D.
    Rajadhyaksha, Manoj
    Staudinger, Heribert
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Ardeleanu, Marius
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (02) : 377 - 388
  • [50] Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study
    Mark G. Lebwohl
    Andrew Blauvelt
    Alan Menter
    Kim A. Papp
    Scott Guenthner
    Radhakrishnan Pillai
    Robert J. Israel
    Abby Jacobson
    [J]. American Journal of Clinical Dermatology, 2019, 20 : 863 - 871
12345